ውድ የኢትዮጵያ ህግ ባለሙያው ሴቶች ማህበር አባላት
ረድኤት ጌታሁን እባላለው የፊልም ተዋናይ ስሆን  አሁን ባለንበት የኮረና 19 ወሸባ ሰአት ሁላችንም በየቤታችን በመሆን የበሽታውን ስርጭት ለመግታት ዬራሳችንን ሀላፊነት በመወጣት ላይ እንደሆንን አስባለው።

በዚህ ሰአት ግን በተለያየ ምክንያት በሴቶችና ህፃናት ላይ  የቤት ውስጥ  ጥቃቶች በመላው አለም እየጨመረ ይገኛል ። ይህንን ጥቃት ለመቀነስና ለማስቆም ግንዛቤ ለማስጨበጥ እንደሴትነቴ ብሎም እንደዜጋና ባለሙያነቴ ሰዎች ትኩረት ሰተው ይሰሙኛል ብዬ ስላሰብኩ ይችን አጭር መልክት እነሆ አዘጋጀው  ስለሆነም በናንተ በኩል ተደራሽ ብታረጓት ብዬ ነው ። ወደፊትም አብሬ መስራት መፈለጌን እጅ በመንሳት እጠይቃለው ።

ከታች የተቆራኘ አጭር የቪዲዮ መልክቱን ያግኙ
እግዚአብሔር ይስጥልኝ 


 https://youtu.be/trXhWfnQXq4

ረድኤት ጌታሁን( የፊልም ተዋናይ)

በለይቶ ማቆያ የሚገኙ ዜጎች አያያዝ ሊገመገም ነው
 
አዲስ አበባ ፣ ሚያዚያ 14 ፣ 2012 (ኤፍ ቢ ሲ)

የአስቸኳይ ጊዜ አዋጅ መርማሪ ቦርድ በለይቶ ማቆያ የሚገኙ ዜጎችን አያያዝ ከነገ ጀምሮ ሊገመግም ነው።

በዚህም መንግስት ለዜጎች የሰጠው ትኩረት እና ዜጎች ያሉበት አጠቃላይ ሁኔታ እንዲሁም ከሰብዓዊ መብት አንጻር ምልከታ እንደሚደረግ መርማሪ ቦርዱ ለፋና ብሮድካስቲንግ ኮርፖሬት ጋር ገልጿል።

በአስቸኳይ ጊዜ አዋጁ አፈጻጸም ላይ ሊያጋጥሙ የሚችሉ 🛑የሰብአዊ መብት ጥሰቶችን 🛑 ለመቆጣጠርም ቦርዱ ክትትል እያደረኩ ነው ብሏል።

በኢትዮጵያ የኮቪድ-19 ስርጭትን ለመቆጣጠር መንግስት ያወጣውን የአስቸኳይ ጊዜ አዋጅ አፈጻጸም የሚከታተል መርማሪ ቦርድ መቋቋሙ ይታወቃል።

ቦርዱ በአስቸኳይ ጊዜ አዋጁ አፈጻጸም ወቅት የሚፈጸሙ የሰብአዊ መብት ጥሰቶችን ተከታትሎ በህግ ፊት ማቅረብ፥ በዚህ ምክንያት ወደ ማረሚያ የሚገቡ ካሉም ከታሰሩበት ተገቢነት አንጻር በመመልከት የምርመራ ውጤቱን ለህዝብ ተወካዮች ምክር ቤት የማቅረብ ሃላፊነት አለበት።

የአስቸኳይ ጊዜ አዋጁ መርማሪ ቦርድ ሰብሳቢ አቶ ጴጥሮስ ወልደሰንበት፥ በህብረተሰቡ ዘንድ ቸልተኝነት እንደሚታይ ለፋና ብሮድካስቲንግ ኮርፖሬት ተናግረዋል።

ዜጎች የወጡ ህጎችን ለራሳቸው ሲሉ በማክበር ጤናቸውን እንዲጠብቁ እና ከጸጥታ አስከባሪዎች ጋር ህግን በማክበር ንትርክ ውስጥ መግባት እንዳይገቡም መልዕክት አስተላልፈዋል።

በሀይለየሱስ መኮንን
Via Ethiopian Legal Brief

https://telegram.me/lawsocieties

Addis Ababa Introduces Even-Odd Scheme To Restrict Private Vehicles From Roads

Addis Ababa, April 17, 2020 (FBC) –Ethiopian capital, Addis Ababa, has introduced a rationing scheme that restricted private vehicles from the roads, effective as of today.

The restriction is part of the State of Emergency declared a week ago to stem the spread of COVID-19 and will remain effective for the coming five months.

The scheme bans private vehicles (Code-2) with odd or even plate numbers from roads on alternate days, according to the Ministry of Transport.

Accordingly, vehicles with even numbers or zeros on their plates are to be used one day, and those with odd numbers the next day, it said.

Regional states will also apply the system by taking into account the reality in their respective regions, the Ministry stated.

The directive banning taxis and cross-country buses from carrying more than 50% of their capacity will be implemented effectively, it added.

https://telegram.me/lawsocieties

Protocol to the African Charter on Human and Peoples’ Rights on the Rights of Older Persons in Africa Ratification Proclamation No.1182-2020
https://telegram.me/lawsocieties

Defense Forces Proclamation No. 1100-2019
https://telegram.me/lawsocieties

BREAKING: Israel Finds Possible 100% Cure For COVID19
https://thedailyvendor.com/breaking-israel-finds-possible-100-cure-for-covid19/

https://telegram.me/lawsocieties

❤️The Israeli COVID19 drug reportedly with a 100% success rate even among severely ill patients is being tested in the United States for the first time.

Pluristem Therapeutics Inc., a biotech company based in Haifa/Israel, reported that seven patients who were at a high risk of death due to respiratory failure, multi-system organ failure, including heart and kidney failure survived after receiving this medication.

The seven patients were treated with Pluristem’s allogeneic placental expanded (PLX) cells.

Essentially, these cells can potentially suppress or reverse the dangerous over-activation of the immune system that causes death in many COVID19 patients.

Now, a critical COVID19 patient in the US has been treated with PLX cell therapy at Holy Name Medical Center in New Jersey. The results of the treatment have yet to be released.

Pluristem Therapeutics uses placentas to grow smart cells and programs them to secrete therapeutic proteins in the bodies of sick people.

Company CEO and President Yaky Yanay said Thursday that a trial will come soon and, once conducted, he hopes that “approval can be very fast.” Upon receiving the green light from regulators, he said, massive quantities of treatment can be prepared.

“We can manufacture cells to treat thousands very quickly,” he said.

Treatment consists of 15-milliliter doses of cells — known as PLacental eXpanded cells — administered in simple inter-muscular injections. Once in the body, Yanay said that the cells become like “a small factory that generates therapeutic proteins.”

He explained: “Most drugs we know are administered in the quantity we need, but this is a ‘drug’ that can sense the human body’s environment, and based on the signals that the cells receive from the body, they secrete therapeutic proteins that push the body toward regeneration.”

The cells secrete two types of proteins. One reduces inflammation; the other is to regulate the immune system. Yanay hopes these so-called immunomodulation proteins can slam the brakes on the immune system to stop it turning on itself, as commonly happens with critical coronavirus patients.

“They stop the body from attacking its own organs by having the placenta cells secrete immunomodulatory factors, basically relaxing the immune system, as the other proteins reduce inflammation,” said Yanay.

He elaborated: “Patients who are in severe condition and dying are actually dying from a severe respiratory condition. What is actually happening is there is a very high level of inflammation and at a certain point the immune system of the patient will attack [the patient], mostly in the lungs.”

Until now, Pluristem’s technology has been largely used to treat people suffering from poor blood flow to the legs, but the company’s scientists were able to quickly repurpose the cells to treat coronavirus patients.

“We take cells from the placenta after full-term delivery and we have developed technology to expand the cells to very large numbers, in an environment that mimics the human body,” Yanay said. “The technology allows us to treat more than 20,000 people from a single placenta.”

His team “programs” the cells, which then have a wide range of proteins they can secrete. The cells don’t just deliver the proteins but also “adjust the level of secretion based on signals they receive from the body,” he said.

Yanay stated that Pluristem, which is based in Haifa, will carry on treating people using patient-by-patient approvals while working as quickly as possible for full approval by regulators.

“We are receiving many inquiries and requests for treatment from health care providers and families worldwide,” he said. “In parallel with our planned clinical trial, we expect to continue treating patients under compassionate use through the appropriate regulatory clearances in the United States and Israel, as well as expanding treatment under compassionate use in other countries.
https://thedailyvendor.com/breaking-israel-finds-possible-100-cure-for-covid19/

“Our main focus remains, however, the initiation of a multinational clinical study,” he said, adding that he was hopeful “cell therapy is a very good candidate to tackle a complex disease that is attacking several organs.”
https://thedailyvendor.com/breaking-israel-finds-possible-100-cure-for-covid19/

ሰበር ዜና
እስራኤል ለ COVID19 100% መድኃኒት አገኘች።
https://telegram.me/lawsocieties

Reporter
#jakenn_publishing_plc
#creative_arts
#journalism
#reporter
Addis Ababa
Bachelors degree in Journalism, Communications, Law, Political Science and International Relations, Economics, Business, and other related degrees
Minimum Years Of Experience: #3_years
Deadline: April 30, 2020
How To Apply: Send your CV to HR@addisstandard.com using format “reference number- [Firstname] [Secondname]” as the subject line
https://telegram.me/Ethiopian_Legal_Advocate

Product Editor
#jakenn_publishing_plc
#creative_arts
#journalism
#news_letter_editor
Addis Ababa
Bachelors degree in Journalism, Communications, Law, Political Science and International Relations, Economics, Business, and other related degrees
Minimum Years Of Experience: #5_years
Deadline: April 30, 2020
How To Apply: Send your CV to HR@addisstandard.com using format “reference number- [Firstname] [Secondname]” as the subject line

https://telegram.me/Ethiopian_Legal_Advocate

#Telegram

የቴሌግራም ወርሃዊ ተጠቃሚዎች ቁጥር 400,000,000 መድረሱን ድርጅቱ አስታውቋል። በቅርቡ አሁን ባለው አገልግሎት ላይ ተጨማሪ ይዘቶችንም እንደሚያካት ይጠበቃል። ድርጅቱ በ2022 1 ቢሊዮን ተጠቃሚዎች እንዲኖሩት እየሰራ ነው።

በነገራችን ላይ በኢትዮጵያም የቴሌግራም ተጠቃሚ ቁጥር በፍጥነት እየጨመረ ነው። ከፍተኛ ተጠቃሚ ካለባቸው ሀገራትም አንዷ እንደሆነች ይነገርላታል፤ በሀገሪቱ ምን ያህል ተጠቃሚ እንዳለ የሚያሳይ አሁናዊ ማስረጃ ባይኖርም።

ከዚህ ቀደም በቴሌግራም ላይ እንቅስቃሴ የማያደርጉ የመንግስት መስሪያ ቤቶች ፣ ሚዲያዎች ፣ ታዋቂ ሰዎችም በስፋት እየተቀላቀሉ ይገኛሉ።

አሁን ደግሞ የኮሮና ቫይረስ ወረርሽኝ ባመጣው ችግር ምክንያት ትምህርት ቤቶች ተማሪዎቻቸውን በቴሌግራም እያስተማሩ እንደሆነም እየሰማን ነው።

ለመሆኑ ይህን ያህል ለምን ተወደደ ?

- ከምንም በላይ ደህንነቱ የተጠበቀ ነው።

- ብዙ ወጪ አያስወጣም፤ በቀላሉ አገልግሎት ይሰጣል። ኔትዎርክ ደካማ በሆነባቸው ቦታዎች ላይም ለመጠቀም አያስቸግርም።

- ማንም ሰው የፈለገው ብቻ መልዕክት ነው የሚደርሰው ፤ ያለፍላጎቱ ምንም መልዕክት እንዳይደረሰው ማድረግ ይችላል።

- ተጠቃሚዎች እርስ በእርስ የሚሰዳደቡበት ዕድል እጅግ በጣም አነስተኛ ነው ፤ ፈልገው ወደ ግሩፖች እና ቻናሎች ካልገቡ በስተቀር።

- የምልዕክት ልውውጥ ቀልጣፋ ነው። በአነስተኛ ገንዘብ የፈለግነውን ፋይሎችን ለመላላክ አመቺ ነው።

ሌሎችም በተጠቃሚዎች በኩል የሚሰጡ ምክንያቶች ብዙ ናቸው!

ቲክቫህ ኢትዮጵያ (TIKVAH-ETH)
https://telegram.me/lawsocieties

Reporter
#independent_news_and_media_plc
#creative_arts
#journalism
#reporter
Addis Ababa
- graduated in Law,political science,journalism,economics,finance or literature
- experience is preferred but is not a strict requirement.
Minimum Years Of Experience: #0_years
Deadline: May 2, 2020
How To Apply: In person ti the following address sierra leone street(debre zeyt road) next to global hotel2 tegene building 7th floor tel: 251 11 41 630 20 fax 251 11 416 3039 P.O.BOX 259 code 1110, Addis Ababa

@Ethiopian_Legal_Advocate
https://telegram.me/Ethiopian_Legal_Advocate

#NewsAlert ‼️

#Ethiopia : ዛሬ በኢትዮጵያ ውስጥ በኮሮና ቫይረስ እንደተያዙ ከታወቀው አምስት ሰዎች ውስጥ አራቱ ቻይናዊያን ሲሆኑ አንዷ ኢትዮጵያዊ መሆኗ ታውቋል::

https://telegram.me/TransparencyEthiopia

apply via
https://www.ethiopianreporterjobs.com/jobs-in-ethiopia/project-coordinator-51/

Adv:
Hi Ale law societies ቤተሰቦች አዲስ አበባ ዩኒቨርስቲ ሐምሌ 4 አስመርቃለሁ ብለዋል። የመውጫ ፈተና /Exit Exam/ በምን መልኩ እና መቼ እንደምንፈተን? ለሚመለከተው አካል መግለጫ/መብራርያ/ እንዲሰጠን በታደርጉልን።

Natnael Mekonnen:
#update

#Ethiopia : አዲስ አበባ ዩንቨርስቲ ከሰዓታት በፊት ያወጣው መግለጫ መደበኛ የመጀመርያ ዲግሪ ተማሪዎችን እንደማይመለከት አሳውቋል።

ለመደበኛ የመጀመሪያ ዲግሪ ተማሪዎች ፈተና መስጠትም ሆነ የምረቃ ፕሮግራም እንደማይካሄድ ዩንቨርስቲው አሳውቋል።

ምንጭ: የዩንቨርስቲው

UPDATE| አዲስ አበባ ዩኒቨርሲቲ

አዲስ አበባ ዩንቨርስቲ ከሰዓታት በፊት ያወጣው መግለጫ መደበኛ የመጀመርያ ዲግሪ ተማሪዎችን እንደማይመለከት አሳውቋል።

ለመደበኛ የመጀመሪያ ዲግሪ ተማሪዎች ፈተና መስጠትም ሆነ የምረቃ ፕሮግራም እንደማይካሄድ ዩንቨርስቲው አሳውቋል።

ምንጭ: የዩንቨርስቲው የፕሬዝዳንት ጽ/ቤት